Long term safety assessment of GW815SF asthma treatment when used in combination with salmeterol xinafoate and fluticasone propionate. - Trial 2015-004882-10
Access comprehensive clinical trial information for 2015-004882-10 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Research & Development Ltd and is currently status unknown. The study focuses on Asthma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2015-004882-10
Trial Details
EU Clinical Trials Register • 2015-004882-10
Long term safety assessment of GW815SF asthma treatment when used in combination with salmeterol xinafoate and fluticasone propionate.
Study Focus
Sponsor & Location
GlaxoSmithKline Research & Development Ltd
GlaxoSmithKline
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Mean change from baseline in morning PEF over Weeks
ICD-10 Classifications
Asthma
Asthma, unspecified
Nonallergic asthma
Mixed asthma
Predominantly allergic asthma
Data Source
EU Clinical Trials Register
2015-004882-10
Non-Device Trial